Hanshiyi Formula

A tradicional Chinese medicine formula.

Phase of research

Potential treatment - clinical evidence

How it helps


Drug status

Natural product

Supporting references
Contradictory references
AI-suggested references
Clinical trials

General information

Hanshiyi Formula is a traditional Chinese medicine prescription approved by the Wuhan Municipal Health Commission for treating mild and moderate COVID-19 (Tian et al., 2020).


Supporting references

Link Tested on Impact factor Notes Publication date
Hanshiyi Formula, a medicine for Sars-CoV2 infection in China, reduced the proportion of mild and moderate COVID-19 patients turning to severe status: A cohort study
Moderate severity Mild severity Mixed substance Cohort study
Patients 5.89

Adjunctive treatment of COVID-19 patients with mild to moderate symptoms with Hanshiyi Formula significantly reduced the progression to severe disease. Sample size: 430 + 291 control. Dosage: As approved and promoted by the Wuhan Municipal Health Commission. Endpoint: Progression to severe disease.